MedPath

Single center, Exploratory Safety Evaluation Study of Transcatheter Closure of Prosthetic Paravalvular Regurgitatio

Not Applicable
Conditions
Prosthetic paravalvular regurgitation after heart valve replacement
Registration Number
JPRN-UMIN000021427
Lead Sponsor
ational Cerebral and Cardiovascular Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
4
Inclusion Criteria

Not provided

Exclusion Criteria

Patients will not be considered for percutaneous repair if the following criteria were met: (1) Patients with metal allergy (2) Patients with allergy to contrast agent (3) Echocardiographic evidence of intra-cardiac mass, thrombus, or vegetation (4) Patients in shock (5) Patients who are or are posslibly, or are lactating (6) Patients who are participating, or going to participate in other clinical studies. (7) Patients judged inappropriate for the study by the principal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Major complication and failure during the procedure Death, stroke, myocardial infarction, cardiac perforation, cardiac tamponade, cardiogenic shock, prosthetic valve failure, major bleeding, injury of great vessels caused by the procedure, embolism of organs, and embolism and/or malposition of the device. 2. Success rate and efficacy of the procedure Acute procedural success was defined as successful deployment of one and more occluder devices that resulted in significant reduction in paravalvular regurgitation to mild or less-residual regurgitation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath